AIA
TEVA icon

Allegis Investment Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Allegis Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-173
Closed -$11K – 835
2015
Q4 		$11K Buy
+173
New +$10.7K 0.01% 651

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Waddell & Reed Financial
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Allegis Investment Advisors's TEVA Position: Q1 2016 in Review

Allegis Investment Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2016, closing a stake of 173 shares — an estimated $11K sold.

Allegis Investment Advisors first reported a position in TEVA in Q4 2015 and held it in 1 quarter. The position peaked at $11K in Q4 2015. 837 funds tracked by Wall St. Rank hold TEVA as of Q1 2016.

  • Allegis Investment Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2016 after selling out during the quarter.
  • Allegis Investment Advisors sold 173 Teva Pharmaceutical Industries Limited shares in Q1 2016, an estimated $11K.
  • Allegis Investment Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q4 2015 and held it in 1 quarter.
  • Allegis Investment Advisors's Teva Pharmaceutical Industries Limited position peaked at $11K in Q4 2015.
  • 837 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2016.

Based on Allegis Investment Advisors's 13F filing for Q1 2016, filed 9 May 2016.